| Detected | Trial | Change |
|---|---|---|
| 2026-08-07 | NCT04104139 TAS-102 With Concurrent Radiation for the Treatment of Untreated Resectable Stage II-III… |
Trial completed |
| 2026-08-07 | NCT04104139 TAS-102 With Concurrent Radiation for the Treatment of Untreated Resectable Stage II-III… |
date change Completion moved earlier: 2026-05-31 -> 2025-07-15 |
| 2026-07-24 | NCT05034627 Calaspargase Pegol-Mnkl and Cobimetinib for the Treatment of Locally Advanced or… |
Trial completed |
| 2026-07-24 | NCT05034627 Calaspargase Pegol-Mnkl and Cobimetinib for the Treatment of Locally Advanced or… |
date change Primary completion moved earlier: 2025-12-16 -> 2025-10-07 |
| 2026-07-24 | NCT05034627 Calaspargase Pegol-Mnkl and Cobimetinib for the Treatment of Locally Advanced or… |
date change Completion moved earlier: 2026-10-01 -> 2026-06-03 |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-07-24 | NCT07726602 Tumor-informed ctDNA in Muscle-invasive Bladder Cancer for Evaluation of… | Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT05919329 | Evaluation of the Change in PSMA Expression in Prostate Cancer in Response to Hormonal… | Castration Resistant Prostate Cancer | Recruiting |
| NCT07405086 | Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or… | Advanced Biliary Tract Carcinoma | Recruiting |
| NCT05722925 | Evaluating Fluciclovine PET in Patients With Biochemical Recurrence of Prostate Cancer… | Prostate Cancer | Active, Not Recruiting |
| Phase 2 | |||
| NCT03649880 | Feasibility of FMISO in Brain Tumors | Malignant Brain Neoplasm | Recruiting |
| NCT06049355 | EMBRACE: Exercising Together | Breast Carcinoma | Recruiting |
| NCT03270059 | Gadolinium and Ferumoxytol MRI in Diagnosing Patients With Abnormalities in the Central… | Central Nervous System Neoplasm | Recruiting |
| NCT06504459 | Venetoclax in Combination With Cladribine and Cytarabine Alternating With Azacitidine… | Acute Monocytic Leukemia | Recruiting |
| NCT06067438 | Amiodarone for the Prevention of Atrial Fibrillation After Minimally Invasive… | Atrial Fibrillation | Recruiting |
| NCT04529044 | 177Lu-DOTATATE for the Treatment of Stage IV or Recurrent Breast Cancer | Anatomic Stage IV Breast Cancer AJCC v8 | Recruiting |
| NCT06895473 | Intrathecal Cytarabine, Methotrexate, and Hydrocortisone for the Prevention of High-Grade… | Hematopoietic and Lymphatic System Neoplasm | Recruiting |
| NCT07228273 | Induction and Consolidation With Fludarabine, Cytarabine, Idarubicin, and Venetoclax for… | Acute Myeloid Leukemia | Recruiting |
| NCT05705492 | Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With… | Advanced Malignant Solid Neoplasm | Recruiting |
| NCT04539808 | NeoOPTIMIZE: Early Switching of mFOLFIRINOX or Gemcitabine/Nab-Paclitaxel Before Surgery… | Pancreatic Adenocarcinoma | Active, Not Recruiting |
| NCT06157099 | Atorvastatin for Preventing Disease Metastasis in Patients With Resected High-Risk Stage… | Pathologic Stage IIIA Cutaneous Melanoma AJCC v8 | Active, Not Recruiting |
| NCT07498517 | Safety and Efficacy of a Single Dose of Gruticibart to Prevent CRT | Thrombosis | Not Yet Recruiting |
| NCT07511504 | Y-90 Radioembolization, Durvalumab, Tremelimumab, and Zanzalintinib for the Treatment of… | Locally Advanced Hepatocellular Carcinoma | Not Yet Recruiting |
| NCT02312557 | Pembrolizumab in Treating Patients With Metastatic Castration Resistant Prostate Cancer… | Castration-Resistant Prostate Carcinoma | Active, Not Recruiting |
| NCT04850599 | Isatuximab, Carfilzomib, and Pomalidomide for the Treatment of Relapsed or Refractory… | Recurrent Plasma Cell Myeloma | Active, Not Recruiting |
| NCT04267887 | Advanced ChemoHormonal Therapy for Treatment Naive Metastatic Prostate Cancer | Castration-Sensitive Prostate Carcinoma | Active, Not Recruiting |
| NCT07434128 | Mammogram Pretreatment With Ulipristal Acetate | Mammography Screening | Not Yet Recruiting |
| Phase 1/2 | |||
| NCT06357676 | Glofitamab Plus Ibrutinib With Obinutuzumab for the Treatment of Patients With Mantle… | Mantle Cell Lymphoma | Recruiting |
| NCT06249191 | Mosunetuzumab With Chemotherapy for the Treatment of Patients With Untreated C-Myc… | Diffuse Large B-Cell Lymphoma | Recruiting |
| NCT06320405 | Axatilimab in Combination With Retifanlimab and Paclitaxel for the Treatment of Patients… | Advanced Malignant Solid Neoplasm | Recruiting |
| NCT05453851 | A Surgical Procedure (Total Pancreatectomy) With a Transplant Procedure (Islet Cell… | Benign Pancreatic Neoplasm | Not Yet Recruiting |
| NCT02522715 | Enzalutamide and Cabazitaxel in Treating Patients With Metastatic, Castration-Resistant… | Castration-Resistant Prostate Carcinoma | Active, Not Recruiting |